share_log

前日に動いた銘柄 part2 ジーダット、大和重工、ダブルエーなど

Stocks that moved the day before, part 2: Zeedat, Daiwa Heavy Industries, Double A, etc.

Fisco Japan ·  Sep 3 18:32

Company name 3-day closing price ⇒ day-over-day change

ITO EN <2593> 3363 -105

Negative view on double-digit operating profit decline in the first quarter.

Laser Tech <6920> 26495 -945

Semiconductor manufacturing equipment is generally biased towards selling, shifting funds towards value.

Sociomext <6526> 3122 -63

Selling pressure spreads as part of the main semiconductor-related segment.

Disco <6146> 40160 -1190

Large-scale semiconductor manufacturing equipment stocks are generally cheap.

Enrai Fi HD <2767> 2035 -7

There is also a sense of caution about the speed of short-term pitch increase.

SUMCO <3436> 1638 -46.5

It is being pushed down by the trend of semiconductor-related stock decline.

Kasumigaseki Capital <3498> 13750 -620

Limited movement of viewing announcements such as M&A as good news.

Sansan <4443> 2174 -53

Particularly, is it a rebalancing of small and medium-sized growth stocks without any material?

Rohm <6963> 1811.0 -27.0

Regarding Shin-Etsu Chemical's Gan substrate development and other material aspects.

ACCESS <4813> 1337 -44

After the settlement, there was a significant rebound on the 2nd day.

Ibiden <4062> 5016 -134

With the sharp rise of the U.S. Intel, the 2nd day is dominated by buying.

Mitsubishi Heavy Industries <5610> 1227 +179

Following the buying trend on the 2nd without any materials.

Gi-DAT <3841> 2300 +400

Continued attention to the signing of the sales agency contract with French company POLLEN as a material.

Image One <2667> 221 +21

Conscious of the struggle for credit supply and demand leading to upward divergence.

CuraMoto Manufacturing <5216> 397 +23

Entered the commercial support robot business through M&A.

Lena Science <4889> 408 +43

Malignant melanoma treatment drug RS5614 designated as an orphan drug.

Karna Bio <4572> 460 +44

The dose expansion part of the Phase 1b trial of the next-generation BTK inhibitor AS-1763 has started.

J Frontier <2934> 1485 -101

Approval for the extension of the submission deadline for the financial statements for the forecast of the fiscal year ending May 2024 has been granted.

Sai Fuse <4892> 660 +20

Selection of new devices for the expansion of the 3D cell product lineup was adopted in the public offering project of Tokyo.

Option.

Sasumed 635 -41

Stop high on the 2nd day in application for approval of partial change in manufacturing and sales approval for insomnia program.

Selling advantage on the 3rd day.

Housei 412 +2

Released the official version of the AI low-code development platform 'imprai'.

Renewable Japan 694 +41

Continued to favorably collaborate with the subsidiary of Mitsui Sumitomo Finance & Lease.

Racquoria Drug Discovery 630 +14

Received sales approval for the gastric acid secretion inhibitor tegoprazan in Colombia.

FLN<9241> 1908 -108

A new company was established on the 2nd to promote regional revitalization projects utilizing AI technology, and its stock price reached the daily upper limit.

On the 3rd, there was selling pressure.

Double A<7683> 1398 +80

The consolidated revenue in August increased by 31% from July's 8% increase, showing an expanded growth rate.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment